MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7326/0003-4819-142-8-200505030-00011

Медицинская библиотека · Annals of internal medicine · 2005

Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.

Merkel Peter A, Lo Grace H, Holbrook Janet T, Tibbs Andrea K, Allen Nancy B, Davis John C, Hoffman Gary S, McCune W Joseph, St Clair E William, Specks Ulrich, Spiera Robert, Petri Michelle, Stone John H, Wegener's Granulomatosis Etanercept Trial Research Group

Клиническое исследованиеСтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Venous thrombotic events (VTEs) have been observed in Wegener granulomatosis, but the incidence rate is not known.

OBJECTIVE

To measure the incidence of VTEs in patients with Wegener granulomatosis.

DESIGN

Prospective, observational cohort study.

SETTING

A multicenter, randomized, double-blind, placebo-controlled treatment trial for Wegener granulomatosis.

PATIENTS: 180 patients with Wegener granulomatosis enrolled during periods of active disease.

MEASUREMENTS: Venous thrombotic events (deep venous thromboses or pulmonary emboli) were documented and confirmed prospectively. Incidence rates were calculated on the basis of time to first VTE.

RESULTS

Thirteen patients had VTEs before enrollment. During 228 person-years of prospective follow-up, 16 VTEs occurred in 167 patients with no history of VTE. Median time from enrollment to VTE for patients with an event was 2.1 months. The incidence of VTE among patients with Wegener granulomatosis was 7.0 per 100 person-years (95% CI, 4.0 to 11.4).

LIMITATIONS: Although prospectively recorded, screening for VTEs did not occur.

CONCLUSIONS

The incidence rate of VTEs in Wegener granulomatosis is high when compared with available rates in the general population, patients with lupus, and patients with rheumatoid arthritis. These results have important implications for clinical care of patients with Wegener granulomatosis.

Для цитирования: Merkel Peter A, Lo Grace H, Holbrook Janet T, Tibbs Andrea K, Allen Nancy B, Davis John C, Hoffman Gary S, McCune W Joseph, St Clair E William, Specks Ulrich, Spiera Robert, Petri Michelle, Stone John H, Wegener's Granulomatosis Etanercept Trial Research Group. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.. Annals of internal medicine. 2005. DOI: 10.7326/0003-4819-142-8-200505030-00011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.